Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:710-711
doi: 10.1161/01.ATV.0000012402.85056.45
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hofnagel, O.
Right arrow Articles by Kume, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hofnagel, O.
Right arrow Articles by Kume, N.
Related Collections
Right arrow Pathophysiology
Right arrow Smooth muscle proliferation and differentiation
Right arrow Lipid and lipoprotein metabolism
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:710.)
© 2002 American Heart Association, Inc.


Letters to the Editor

Expression of the Novel Scavenger Receptor SR-PSOX in Cultured Aortic Smooth Muscle Cells and Umbilical Endothelial Cells

Oliver Hofnagel; Birgit Luechtenborg; Gabriele Plenz; Horst Robenek

Institute for Arteriosclerosis Research
University of Muenster
Muenster, Germany

To the Editor:

In the November issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Minami et al1 demonstrated expression of the novel scavenger receptor for phosphatidylserine and oxidized lipoprotein (SR-PSOX) in lipid-laden macrophages accumulated in the intima of human atherosclerotic lesions. Because SR-PSOX seems to be identical to the membrane-anchored chemokine CXCL16,2,3 which may play a dual role in inflammation and homeostasis, Minami et al1 discussed the potential regulation of SR-PSOX by pro-inflammatory cytokines. Although the authors did not detect SR-PSOX in smooth muscle cells (SMCs) and endothelial cells (ECs), they did discuss the possible expression of SR-PSOX in these cell types. Until now, only the expression of the scavenger receptors SR-AI/II,4 CD36,5 and LOX-16 in SMCs has been described.

In our studies on the formation of SMC-derived foam cells during atherogenesis, we have focused on the expression of scavenger receptors,7 including SR-PSOX, in SMCs and ECs. We have also investigated the influence of cytokines on the expression of SR-PSOX in SMCs. Reverse transcriptase–polymerase chain reaction (PCR; primers for human SR-PSOX: 5'-TACACGAGGTTCCAGCTCCT-3' and 5'-GGGGGCTGGT- AGGAAGTAAA-3', porcine SR-PSOX: 5'-TATGTGGAGGCAGCAG- TGAC-3' and 5'-CTGCAGGGTAGATGGCAGAT-3') was performed on total RNA from cultured human and porcine aortic SMCs and human umbilical vein endothelial cells (HUVECs). PCR was performed at 94°C (45 seconds), 58°C (60 seconds), and 72°C (60 seconds) for 20 to 40 cycles in the linear area of amplification. The sequences of SR-PSOX products were confirmed by sequence analysis. ß-Actin served as the internal standard.

Thus, reverse transcriptase–PCR demonstrated the expression of SR-PSOX mRNA in porcine and . . . [Full Text of this Article]

Noriaki Kume

Department of Geriatric Medicine
Graduate School of Medicine
Kyoto University
Kyoto, Japan




This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
K. YANABA, E. MUROI, A. YOSHIZAKI, T. HARA, F. OGAWA, K. SHIMIZU, M. YOZAKI, M. HASEGAWA, M. FUJIMOTO, K. TAKEHARA, et al.
Serum CXCL16 Concentrations Correlate with the Extent of Skin Sclerosis in Patients with Systemic Sclerosis
J Rheumatol, September 1, 2009; 36(9): 1917 - 1923.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Gutwein, M. S. Abdel-Bakky, A. Schramme, K. Doberstein, N. Kampfer-Kolb, K. Amann, I. A. Hauser, N. Obermuller, C. Bartel, A.-A. H. Abdel-Aziz, et al.
CXCL16 Is Expressed in Podocytes and Acts as a Scavenger Receptor for Oxidized Low-Density Lipoprotein
Am. J. Pathol., June 1, 2009; 174(6): 2061 - 2072.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. H. Yang, S. J. Kim, N. Kim, J. E. Oh, J. G. Lee, N. H. Chung, S. Kim, and Y. S. Kim
NKT Cells Inhibit the Development of Experimental Crescentic Glomerulonephritis
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1663 - 1671.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Galkina, B. L. Harry, A. Ludwig, E. A. Liehn, J. M. Sanders, A. Bruce, C. Weber, and K. Ley
CXCR6 Promotes Atherosclerosis by Supporting T-Cell Homing, Interferon-{gamma} Production, and Macrophage Accumulation in the Aortic Wall
Circulation, October 16, 2007; 116(16): 1801 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Tohyama, K. Sayama, H. Komatsuzawa, Y. Hanakawa, Y. Shirakata, X. Dai, L. Yang, S. Tokumaru, H. Nagai, S. Hirakawa, et al.
CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes
Int. Immunol., September 1, 2007; 19(9): 1095 - 1102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. M. Okamura, J. M. Lopez-Guisa, K. Koelsch, S. Collins, and A. A. Eddy
Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F575 - F585.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. E. Garcia, L. D. Truong, P. Li, P. Zhang, R. J. Johnson, C. B. Wilson, and L. Feng
Inhibition of CXCL16 Attenuates Inflammatory and Progressive Phases of Anti-Glomerular Basement Membrane Antibody-Associated Glomerulonephritis
Am. J. Pathol., May 1, 2007; 170(5): 1485 - 1496.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Lehrke, S. C. Millington, M. Lefterova, R. G. Cumaranatunge, P. Szapary, R. Wilensky, D. J. Rader, M. A. Lazar, and M. P. Reilly
CXCL16 Is a Marker of Inflammation, Atherosclerosis, and Acute Coronary Syndromes in Humans
J. Am. Coll. Cardiol., January 30, 2007; 49(4): 442 - 449.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Aslanian and I. F. Charo
Targeted Disruption of the Scavenger Receptor and Chemokine CXCL16 Accelerates Atherosclerosis
Circulation, August 8, 2006; 114(6): 583 - 590.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. R. Greaves and S. Gordon
Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors
J. Lipid Res., January 1, 2005; 46(1): 11 - 20.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Chandrasekar, S. Bysani, and S. Mummidi
CXCL16 Signals via Gi, Phosphatidylinositol 3-Kinase, Akt, I{kappa}B Kinase, and Nuclear Factor-{kappa}B and Induces Cell-Cell Adhesion and Aortic Smooth Muscle Cell Proliferation
J. Biol. Chem., January 30, 2004; 279(5): 3188 - 3196.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. OSTERUD and E. BJORKLID
Role of Monocytes in Atherogenesis
Physiol Rev, October 1, 2003; 83(4): 1069 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Shashkin, D. Simpson, V. Mishin, B. Chesnutt, and K. Ley
Expression of CXCL16 in Human T Cells
Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 148 - 149.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. C. Schulze, E. Kluge, G. Schuler, B. Lauer, O. Hofnagel, H. Robenek, N. Kume, M. Minami, T. Shimaoka, S. Yonehara, et al.
Periprocedural Kinetics in Serum Levels of Cytokines and Adhesion Molecules in Elective PTCA and Stent Implantation: Impact on Restenosis * *
Arterioscler Thromb Vasc Biol, December 1, 2002; 22 (12): 2105 - 2107.
[Full Text] [PDF]